Literature DB >> 7527394

Intact and functional fibroblast growth factor (FGF) receptor-1 trafficks near the nucleus in response to FGF-1.

I Prudovsky1, N Savion, X Zhan, R Friesel, J Xu, J Hou, W L McKeehan, T Maciag.   

Abstract

Exogenous fibroblast growth factor-1 (FGF-1) associates with the nucleus in a receptor-dependent manner during the entire G1 period of the BALB/c 3T3 cell cycle (Zhan, X., Hu, X., Friesel, R., and Maciag, T. (1993) J. Biol. Chem. 268, 9611-9620). To further study the role of the FGF receptor (FGFR) during this translocation, the intracellular fate of FGFR-1 protein and enzymatic activity was examined. Immunoprecipitation using multiple FGFR-1 antibodies followed by an in vitro tyrosine kinase activity assay enabled us to identify FGFR-1 as a 130-kDa phosphotyrosine-containing protein associated with the nuclear fraction of NIH 3T3 cells exposed to FGF-1. While FGFR-1 tyrosine kinase activity could be detected as a nuclear-associated protein after a 2-h exposure of the NIH 3T3 cells to FGF-1, this activity appeared to be maximal in the nuclear fraction between 4 and 12 h after FGF-1 treatment. In addition, analysis by confocal immunofluorescence microscopy of quiescent and FGF-1-stimulated NIH 3T3 cells reveal a prominent perinuclear FGFR-1 staining pattern in the cells exposed to FGF-1 but not in the quiescent population. We also observed FGFR-1 associated with the nuclear fraction in FGFR-1-transfected L6 rat myoblasts, which are known to be refractive to exogenous FGF-1 and express relatively low levels of endogenous FGFR-1. In addition, these cells also exhibited the presence of a 145-kDa phosphoprotein in the nuclear fraction that was recognized by FGFR-1 antibodies. These results suggest that the FGFR-1 may be translocated near the nucleus upon interaction with its ligand during the entire G1 period of the NIH 3T3 cell cycle as a structurally intact and functional tyrosine kinase that may be accessible to perinuclear polypeptides as a regulatory enzyme.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527394

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle.

Authors:  Eugene Jang; Hassan Albadawi; Michael T Watkins; Elazer R Edelman; Aaron B Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain.

Authors:  M K Webster; D J Donoghue
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

3.  Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells.

Authors:  M K Stachowiak; P A Maher; A Joy; E Mordechai; E K Stachowiak
Journal:  Mol Biol Cell       Date:  1996-08       Impact factor: 4.138

4.  Basic fibroblast growth factor regulates extracellular matrix and contractile protein expression independent of proliferation in vascular smooth muscle cells.

Authors:  S Kato; A Muraishi; T Miyamoto; J C Fox
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

5.  A requirement for fibroblast growth factor in regulation of skeletal muscle growth and differentiation cannot be replaced by activation of platelet-derived growth factor signaling pathways.

Authors:  A J Kudla; M L John; D F Bowen-Pope; B Rainish; B B Olwin
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

6.  Basic fibroblast growth factor (Fgf2) is necessary for cell proliferation and neurogenesis in the developing cerebral cortex.

Authors:  R Raballo; J Rhee; R Lyn-Cook; J F Leckman; M L Schwartz; F M Vaccarino
Journal:  J Neurosci       Date:  2000-07-01       Impact factor: 6.167

7.  Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors.

Authors:  H Peng; J Moffett; J Myers; X Fang; E K Stachowiak; P Maher; E Kratz; J Hines; S J Fluharty; E Mizukoshi; D C Bloom; M K Stachowiak
Journal:  Mol Biol Cell       Date:  2001-02       Impact factor: 4.138

Review 8.  Normal morphogenesis of epithelial tissues and progression of epithelial tumors.

Authors:  Chun-Chao Wang; Leen Jamal; Kevin A Janes
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2011-09-02

9.  Dendrimer-based tumor cell targeting of fibroblast growth factor-1.

Authors:  Thommey P Thomas; Rameshwer Shukla; Alina Kotlyar; Jola Kukowska-Latallo; James R Baker
Journal:  Bioorg Med Chem Lett       Date:  2009-12-03       Impact factor: 2.823

10.  Construction and characterization of a thrombin-resistant designer FGF-based collagen binding domain angiogen.

Authors:  Luke P Brewster; Cicely Washington; Eric M Brey; Andrew Gassman; Anu Subramanian; Jen Calceterra; William Wolf; Connie L Hall; William H Velander; Wilson H Burgess; Howard P Greisler
Journal:  Biomaterials       Date:  2007-10-22       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.